Alvotech Warrant 2022-open end on
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.2303 USD
−231.86 M USD
489.68 M USD
97.85 M
About Alvotech
Sector
Industry
CEO
Vilhelm Róbert Wessman
Website
Headquarters
Luxembourg
Founded
2021
Identifiers
2
ISIN LU2458333858
Alvotech is a biotechnology company, which engages in the development and manufacture of biosimilar medicines. The firm is focusing on the development of its product candidates. It operates through the following geographical segments: Europe, North America, Asia, and Other. The company was founded by Róbert Vilhelm Wessman in 2013 and is headquartered in Luxembourg.
Displays a symbol's price movements over previous years to identify recurring trends.